Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.
- NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_assertion description "[Thus, CD34 selection of PBPCs markedly reduces tumor contamination in multiple myeloma and provides effective hematopoietic support for patients receiving myeloablative therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.
- NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_assertion evidence source_evidence_literature NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.
- NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_assertion SIO_000772 7540888 NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.
- NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_assertion wasDerivedFrom befree-20140225 NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.
- NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_assertion wasGeneratedBy ECO_0000203 NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP444270.RAfONKLriS2-1dHKItwESywcFElLtm9-GuJgRqAmshNZI130_provenance.